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Osteopontin expression in progressive renal injury in remnant tactic molecule [1–3]. A wide range of cell types has been
kidney: Role of angiotensin II. shown to express OPN in a constitutive or inducible
Background. Osteopontin (OPN) is a macrophage chemo- fashion, including osteoclasts, some epithelial cells, mac-tactic and adhesion molecule and has been shown to play a
rophages, T cells, smooth muscle cells, and some tumorsrole in glomerular and tubulointerstitial injury in several kidney
[4–9]. The functional importance of OPN in the recruit-disease models.
Methods. The present study examined whether OPN expres- ment of macrophages has been recently documented in
sion is involved in the progression of renal disease following vivo [10, 11]. Indeed, OPN can bind avidly to macro-
subtotal (5/6) nephrectomy (STNx) in rats and whether angio-
phages and induces prominent monocyte infiltrationtensin II (Ang II) mediates the up-regulation of renal OPN ex-
when injected subcutaneously in mice [10]. Furthermore,pression and macrophage accumulation in this model by adminis-
tering valsartan, an Ang II type I (AT1) receptor antagonist, or macrophage accumulation induced by intradermal injec-
ramipril, an angiotensin-converting enzyme (ACE) inhibitor. tion of the chemoattractant N-formyl-met-leu-phe in rats
Results. In normal and sham-operated rat kidneys, OPN was
is inhibited by the administration of a neutralizing anti-expressed in a few tubules (,5%) and was absent in glomeruli.
OPN antibody [11].Following STNx (weeks 2 to 16), there was substantial up-regu-
lation of OPN mRNA and protein expression in glomeruli [2 A strong association between the up-regulation of
to 12 cells/glomerular cross section (gcs)] and tubular epithelial OPN expression and macrophage infiltration has been
cells (20 to 75% OPN1). The up-regulation of OPN expression described in a wide range of experimental models ofwas associated with macrophage accumulation within the kid-
glomerular and interstitial nephritis [12–22]. Both theney, severe proteinuria, loss of renal function, and severe histo-
logic damage, including tubulitis and tubulointerstitial fibrosis degree of OPN up-regulation in the tubules and the sites
(all P , 0.001). Treatment with either valsartan or ramipril com- of its localization have been shown to correlate with the
pletely abrogated the up-regulation of OPN mRNA and pro- sites and degree of macrophage accumulation and thetein expression in glomeruli and tubules. The reduction in OPN
severity of tubulointerstitial fibrosis and renal impair-expression was associated with a significant inhibition of macro-
ment [14]. Most convincing have been recent studiesphage accumulation and progressive renal injury (P , 0.001).
Conclusion. An up-regulation of OPN expression may play in which OPN expression has either been inhibited or
a role in progressive renal injury following STNx. Inhibition neutralized. The administration of anti-OPN antibody
of OPN expression may be one of the mechanisms by which
to a model of rat crescentic antiglomerular basementAng II blockade attenuated renal injury after renal ablation.
membrane (GBM) glomerulonephritis resulted in a re-
markable inhibition of both glomerular and tubulointer-
stitial macrophage accumulation and a reduction in dis-Osteopontin (OPN) is a highly acidic glycoprotein con-
ease severity [23]. In addition, the importance of OPNtaining an adhesive arginine-glycine-aspartic acid se-
in mediating macrophage-rich tubulointerstitial injuryquence and acts as a macrophage adhesion and chemo-
has recently been delineated in OPN2/2 mice in a model
of unilateral obstructive nephropathy [22].Key words: macrophages, valsartan, rampiril, nephrectomy, adhesion
molecule, tubulointerstitial injury. Angiotensin II (Ang II) has been shown to play a
role in macrophage-mediated tubulointerstitial injury in
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has also been shown to stimulate OPN expression in tu- rats was used as a sham surgery control group. Animals
bules in vitro [26] and to induce OPN expression in were sacrificed 12 weeks after surgery.
tubules in vivo, the latter followed by macrophage infil- The experiments were approved by the Animal Wel-
tration and the development of tubulointerstitial disease fare and Ethics Committee of the Austin and Repatria-
[13]. Furthermore, in the unilateral ureteral obstruction tion Medical Center.
model, the administration of angiotensin-converting en-
Blood pressure and renal functionzyme (ACE) inhibitors was shown to reduce both OPN
expression and the macrophage infiltration, suggesting Systolic blood pressure was monitored weekly in con-
a potential causal link [27]. In contrast, in the streptozo- scious rats using an occlusive tail-cuff plethysmograph
tocin model of diabetes, the administration of ACE in- attached to a pneumatic pulse transducer (Narco Bio-
hibitors actually increased OPN expression in tubules system, Houston, TX, USA). Prior to sacrifice, rats were
via a bradykinin-dependent effect, and the OPN expres- housed in metabolic cages for 24 hours for urine collec-
sion in this model did not correlate with macrophage tion. Total urinary protein excretion was measured using
infiltration or injury [28]. Given these contrasting results, the Coomassie Brilliant Blue Method. At the time of
we sought to determine whether OPN expression is in- sacrifice, serum was collected for measurement of urea
creased in the remnant kidney model and whether its and creatinine concentrations.
expression is associated with macrophage infiltration and
renal injury. Furthermore, we examined the role of Ang Histopathology
II in the regulation of OPN expression in this model by Renal tissues were fixed in 10% neutral-buffered for-
administering either an ACE inhibitor or an angiotensin malin and were embedded in paraffin. Four-micron par-
type I (AT1) receptor antagonist. affin sections were stained with hematoxylin and periodic
acid-Schiff (PAS) or with Masson’s trichrome. Glomeru-
losclerosis was assessed on PAS-stained sections using aMETHODS
slightly modified version of the semiquantitative scoringExperimental design
method [24, 29]. The extent of tubulointerstitial injury
The present study consisted of two experimental pro- was evaluated on trichrome-stained sections to assess
tocols that have been described previously [24, 29]. The the relative proportion of tubular dilation, tubular atro-
first experiment contained 50 male Sprague-Dawley rats phy, and interstitial fibrosis, using a standard point-
(weighing 200 to 250 g). Rats were obtained from the
counting technique [24, 29]. In addition, tubulitis was
Animal House, Repatriation Campus (A & R Medical
also used as an index of severe tubular injury. This wasCenter, Heidelberg, Australia). Twenty-five animals un-
assessed by the presence of more than two ED11 macro-derwent STNx consisting of right subcapsular nephrec-
phages infiltrating within the tubules defined by the ED1tomy and infarction of approximately two thirds of the
monoclonal antibody (mAb) labeling on PAS counter-left kidney by selective ligation of two of the three extra-
stained tissue sections. Data were expressed as a percent-renal branches of the left renal artery. At the same time,
age of tubules exhibiting tubular lesions.25 rats underwent a sham surgical procedure (control
group) consisting of laparotomy and tactile manipulation Immunohistochemistry
of left kidney before wound closure. All animals were
Immunohistochemical staining for OPN protein andhoused in a temperature-controlled (228C) room with ad
macrophage accumulation was performed on formalin-libitum access to commercial standard rat chow (Norco,
fixed, paraffin-embedded sections using a microwave an-Lismore, N.S.W., Australia) and water for the duration
tigen retrieval method [5, 30]. Sections were dewaxedof the study. Groups of five animals in both STNx and
and treated with 10 minutes of microwave oven heatingsham groups were killed at 2, 4, 8, 12, or 16 weeks after
in 400 mL of 0.01 mol/L sodium citrate, pH 6.0, at 2450surgery. In addition, one group of five normal rats was
MHz and 800 W. After preincubation with 10% fetal calfused as the normal control.
serum (FCS) and 10% normal goat serum in phosphate-The second experiment consisted of 32 male Sprague-
buffered saline (PBS) for 20 minutes, sections wereDawley rats weighing 200 to 250 g. Twenty-four animals
drained and then labeled with mouse mAbs to rat OPNunderwent STNx as described previously in this article.
(MPIIIB10; obtained from the Developmental StudiesAfter the surgery, the rats were randomly assigned into
Hybridoma Bank, Iowa City, IA, USA) or rat macro-three groups: (1) STNx alone (N 5 8), (2) STNx with
phages (ED1) for 60 minutes, washed (three times) inan ACE inhibitor, ramipril (STNxR; 3 mg/L drinking
PBS, and endogenous peroxidase inactivated by incuba-water, N 5 8; Hoechst AG, Frankfurt, Germany), and
tion in 0.3% H2O2 in methanol. Sections then were(3) STNxV with an AT1 receptor antagonist, valsartan
washed in PBS, incubated with peroxidase-conjugated(STNxV; 30 mg/kg/day by daily gavage, N 5 8; Ciba-
Geigy, Basel, Switzerland). In addition, a group of eight goat anti-mouse IgG, washed in PBS, incubated with
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mouse peroxidase antiperoxidase complexes, and devel- tutes of Health and available on the Internet at http://
oped with 3,3-diaminobenzidine to produce a brown color. rsb.info.nih.gov/nih-image/).
Double immunostaining was used to detect OPN and
In situ hybridizationmacrophages within the same section. Once staining with
the ED1 mAb was completed, as described previously In situ hybridization was performed on 4 mm paraffin
in this article, sections were given a second round of sections of formalin-fixed tissue using a microwave-based
microwave oven heating to block antibody cross-reactiv- protocol as described in detail elsewhere [5, 23, 31]. After
ity and enhance detection of OPN. Following precincu- dewaxing, sections were treated with a microwave oven
bation, as described previously in this article, sections for 2 3 5 minutes as described previously in this article,
were incubated with the MPIIIB10 mAb and then incu- incubated with 0.2 mol/L HCl for 15 minutes, followed
bated sequentially with alkaline phosphatase-conjugated by 1% Triton X-100 for 15 minutes, and then digested
goat anti-mouse IgG and mouse alkaline phosphatase for 20 minutes with 10 mg/mL Proteinase-K at 378C
antialkaline phosphatase complexes and developed with (Boehringer Mannheim). Sections then were washed in
Fast Blue BB Salt (Ajax Chemicals, Melbourne, Austra- 2 3 SSC, prehybridized, and then hybridized with 0.3
lia). No staining was seen in negative control sections
ng/mL DIG-labeled sense or antisense OPN cRNA
using the 73.5 IgG1 (anti-human CD45R) irrelevant iso-
probe overnight at 378C in a hybridization buffer con-type control mAb. All peroxidase and alkaline phospha-
taining 50% deionized formamide, 4 3 SSC, 2 3 Den-tase-conjugated antibodies and complexes were pur-
hardt’s solution, 1 mg/mL salmon sperm DNA, and 1chased from Dakopatts (Glostrup, Denmark).
mg/mL yeast tRNA. Sections were washed finally in
0.1 3 SSC at 378C, and the hybridized probe was detectedProbes
using sheep anti-DIG antibody (Fab) conjugated withA 1 kb cRNA probe was generated from the 2B7 cDNA
alkaline phosphatase and color development with NBT/clone of rat smooth muscle OPN [8]. Sense and antisense
X-phosphate (Boehringer Mannheim). Sections werecRNA probes were labeled with digoxigenin (DIG)-
mounted in an aqueous medium. No signal was seen withUTP using a T7 RNA polymerase kit (Boehringer Mann-
the sense riboprobe labeled to the same specific activity.heim GmbH, Mannheim, Germany). In addition, a 358
bp fragment of rat glyceraldehyde-3-phosphate dehydro-
Quantitation of in situ hybridization andgenase (GAPDH) cDNA was amplified by reverse tran-
immunohistochemistry stainingscription-polymerase chain reaction (RT-PCR) and la-
beled with DIG-dUTP using the High-Prime random Positively stained cells were quantitated in tissue sec-
priming kit (Boehringer Mannheim GmbH). Probes tions as previously described [5, 23]. Briefly, the number
were precipitated, and incorporation of DIG was deter- of cells labeled with the OPN cRNA probe or the differ-
mined by dot blotting. ent mAb was counted in at least 50 glomeruli cross-
sections per animal. Interstitial ED11 macrophages were
Northern blot analysis counted in at least 20 consecutive high-power fields mov-
Northern blotting was performed as previously de- ing from the outer cortex to the inner cortex by means
scribed [5, 23]. Briefly, total cellular RNA was extracted of a 0.02 mm2 graticule fitted in the eyepiece of micro-
using the RNAzol reagent (GIBCO BRL, Gaithersburg, scope. The number of tubules positive for OPN mRNA
MD, USA), and 20 mg samples were denatured with gly- and protein was scored from at least 1000 cortical tu-
oxal and dimethylsulfoxide, size fractionated on 1.2% aga- bules. In addition, a point-counting technique was used
rose gels, and capillary blotted onto positively charged to quantitate the number of interstitial ED11 cells sur-
nylon membranes (Boehringer Mannheim). Membranes
rounding OPN1 or OPN2 tubules. The number of ED11
were hybridized overnight at 688C or 428C with DIG-
macrophages that are immediately surrounding and/orlabeled cRNA or cDNA probes, respectively, in DIG
infiltrating either OPN1 or OPN2 tubules was countedEasy Hyb solution (Boehringer Mannheim). Following
using at least 1000 cortical tubules and expressed ashybridization, membranes were washed finally in 0.1 3
ED11 cells/tubules per animal. Finally, OPN1 or OPN2standard saline citrate (SSC)/0.1% sodium dodecyl sul-
cortical tubules were assessed for tubulitis by scoring thefate (SDS) at 688C or 0.2 3 SSC/0.1% SDS at 428C.
presence of ED11 macrophages between and/or withinBound probes were detected using sheep anti-DIG anti-
the tubules in at least 1000 cortical tubules per animal.body (Fab) conjugated with alkaline phosphatase and de-
Data are expressed as the mean 6 SEM for groups ofvelopment with CPD-star enhanced chemiluminescence
six animals.(Boehringer Mannheim). Chemiluminescence emissions
All morphological analysis and cell counting were per-were captured on Kodak XAR film, and densitometry
formed on blinded slides, and the areas evaluated wereanalysis was performed using the public domain NIH
ImagePC program (developed at the U.S. National Insti- in the renal cortex at a site distant from the surgical infarct.
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Statistical analyses preceded the development of significant macrophage in-
filtration at week 4 (Fig. 3), demonstrating that up-regu-One-way analysis of variance (ANOVA) from the Com-
lation of renal OPN temporally precedes the macro-plete Statistical Analysis program (CSS, Statsoft, Tulsa,
phage accumulation following renal ablation. Notably,OK, USA) was used to analyze differences in clinical
OPN mRNA and protein expression by cortical tubulesdata and quantitative immunohistochemistry scoring.
continued to increase throughout the disease course,The Pearson single-correlation coefficient was used to
eventually being positive in up to 80% of tubules (Figs.compare OPN protein expression with macrophage and
1d and 3B). The OPN expression was paralleled by pro-T-cell accumulation, proteinuria, and renal impairment.
gressive macrophage accumulation and tubulointerstitialThe relationship between OPN expression and glomeru-
damage over weeks 4 to 16 (Figs. 1c, d; 2c, d; and 3B, D).lar and tubulointerstitial damage was compared using
In situ hybridization and double immunohistochemistrythe Spearman’s rank correlation coefficient.
staining showed that the marked up-regulation of tubular
OPN mRNA and protein expression occurred in areas
RESULTS of focal tubulointerstitial macrophage infiltration, re-
Histology, renal function, and blood pressure sulting in the development of macrophage-rich tubulitis
and tubulointerstitial fibrosis (Figs. 1c, d and 2c, d). InFollowing STNx, rats developed elevated systolic blood
contrast, there was minimal macrophage accumulationpressures, heavy proteinuria, renal insufficiency, progres-
in the areas where tubular OPN expression was absentsive glomerulosclerosis, and tubulointerstitial disease as
(Fig. 2c). Quantitative analysis confirmed that most infil-described previously [24, 29]. All of these parameters
trating peritubular macrophages accumulated aroundremained within the normal range in the sham-operated
OPN1 tubules (Fig. 4A) and that the incidence of tubul-control group for the duration of the experiment [24, 29].
itis was much greater in OPN1 tubules as compared with
OPN expression in normal and sham-operated OPN2 tubules (Fig. 4B).
rat kidneys
Correlation of OPN expression with macrophageIn normal rat kidney, in situ hybridization and immu-
accumulation and progressive renal injurynostaining identified the constitutive expression of OPN
As shown in Table 1, the number of glomerular andmRNA and protein in some distal tubules and in thick
tubular OPN1 cells correlated significantly with the num-ascending limbs of the loop of Henle, accounting for less
ber of ED11 macrophages within the tubulointerstitium,than 5% (3.361.8%) of all cortical tubules (Figs. 1a, 2a,
the presence of tubulitis and tubulointerstitial fibrosis,and 3B). There were no OPN-positive cells within the
and proteinuria and the loss of renal function over theglomerulus (Figs. 1a, 2a, and 3A). Similarly, there was no
16-week time course following renal ablation.increase in the number of glomerular or tubular OPN
mRNA and protein-positive cells in sham-operated kid-
Inhibition of OPN expression, macrophageneys throughout the 16-week period of observation (Figs.
accumulation, and progressive renal injury by2b and 3A, B). There was also no increase in ED11 macro-
Ang II blockadephages within glomeruli and tubulointerstitium in all
Double immunostaining, in situ hybridization, andsham-operated kidneys (Figs. 2b and 3C, D).
Northern blotting demonstrated a marked up-regulation
Up-regulation of OPN expression, macrophage of OPN mRNA and protein expression within the kidney
accumulation, and renal injury following STNx in control animals 12 weeks following STNx (Figs. 1d,
2d, 5, and 6). This was particularly striking within theIn situ hybridization and immunostaining showed a
damaged tubulointerstitium. The up-regulation of tubu-significant increase in the number of OPN1 glomerular
lar OPN mRNA and protein expression was associatedand tubular cells at week 2 following STNx (Figs. 1b, 2c,
with focal infiltration of ED11 macrophages and the devel-and 3A, B). An important observation was that the de
novo OPN expression by proximal tubules at week 2 opment of severe tubulointerstitial damage such as tubu-
c
Fig. 1. In situ hybridization showing osteopontin (OPN) mRNA expression in the rat remnant kidney. (a) Normal rat kidney showing no OPN
mRNA expression within the glomerular tuft, but OPN expression (black) is seen in the thick ascending limbs of Henle. (b) Week 2 following
STNx, showing de novo OPN mRNA expression by proximal tubules surrounding a glomerulus and in some glomerular parietal epithelial cells.
(c) Week 8 after STNx, showing marked OPN expression by many tubules and some glomerular cells. (d) Week 12 of untreated animal (STNx)
showing strong OPN mRNA expression within areas of severe tissue damage, including early glomerular crescents (*) and sites of tubular atrophy,
hypertrophy, and fibrosis. In contrast, treatment with valsartan (e) or ramipril ( f ) for 12 weeks after renal ablation completely abrogated the
increase in OPN mRNA expression within glomeruli and tubules (original magnification 3250).
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Fig. 3. Quantitation of OPN mRNA and protein expression in rat remnant kidney. (A and B) The number of glomerular cells and tubules
expressing OPN mRNA (d) or protein (h) was scored in tissue sections from sham-operated (dashed lines) or subtotal nephrectomized (STNx;
solid lines) animals. Note that a significant increase in OPN expression is evident at week 2 and continues to increase over the 16-week time
course after renal ablation. There is no change in OPN expression in sham controls. (C and D) Similarly, there is no increase in the number of
ED11 macrophages over the entire experimental time course in sham-operated animals (dashed lines). However, the number of ED11 macrophages
within the glomerulus and tubulointerstitium is markedly increased over 4 to 16 weeks following STNx (solid lines). Data are expressed as mean 6
SEM for five animals. *P , 0.05; **P , 0.01; ***P , 0.001 by ANOVA.
lar hypertrophy, macrophage-rich tubulitis, and intersti- lar up-regulation of OPN mRNA and protein expression
was nearly abrogated (Figs. 1e, f, 2e, f, 5, and 6). Thetial fibrosis (Figs. 1d, 2d, 5, 6, and 7). In addition, the
up-regulation of OPN expression by glomerular parietal decrease in OPN expression was associated with a sig-
nificant reduction of macrophage accumulation withinepithelial cells was found to be associated with early
glomerular crescent formation (Fig. 1d). In contrast, in the glomeruli [6.6 6 1.9 cells/glomerular cross-section
(gcs) in STNx vs. 3.0 6 0.3 cells/gcs in STNxV and 1.9 6rats administered the AT1 receptor antagonist valsartan
or the ACE inhibitor ramipril, the glomerular and tubu- 0.5 cells/gcs in STNxR, P , 0.05 or , 0.01, respectively]
b
Fig. 2. Double immunohistochemistry staining showing OPN protein expression and macrophage accumulation in the rat remnant kidney. (a) A
normal rat kidney showing a few tubules with OPN protein expression (blue). A few ED11 macrophages are seen within the interstitium (red).
(b) Week 12 of sham-operated kidney showing a similar pattern of OPN expression and macrophage accumulation as seen in normal rats (a). (c)
Week 4 of STNx kidney showing that focal tubular OPN expression is associated with ED11 macrophage infiltration and the development of
tubulitis (*), whereas minimal OPN expression and few infiltrating macrophages are seen in an area with no apparent damage. (d) Week 12 of
untreated kidney (STNx) showing a marked tubular OPN up-regulation and macrophage accumulation. Note the colocalization of tubular OPN
expression and numerous infiltrating macrophages with extensive tubulitis (*) and tubulointerstitial fibrosis. In contrast, valsartan-treated (e) and
ramipril-treated ( f ) animals showing a complete inhibition of OPN expression and macrophage accumulation and histologic damage. Sections
were counterstained with PAS (original magnification 3250).
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and in the cortical tubulointerstitium (394 6 l68 cells/
mm2 vs. 179 6 33 cells/mm2 in STNxV and 136 6 l43
cells/mm2 in STNxR, P , 0.01, respectively). This was
associated with a substantial inhibition of tubulitis (Fig.
7). In addition, valsartan or ramipril treatment was also
associated with a reduction of proteinuria (156 6 36 in
STNx vs. 65 6 17 in STNxV and 58 6 20 mg/24 h in
STNxR, P , 0.01, respectively), a less decline in creati-
nine clearance (0.6 6 0.2 in STNx vs. 1.8 6 0.3 in STNxV
and 1.6 6 0.4 mL/min in STNxR, P , 0.05) and less
glomerulosclerosis (index: 0.9 in STNx vs. 0.2 in STNxV
and STNxR, P , 0.01) and tubulointerstitial fibrosis (in-
dex: 5.5 in STNx vs. 0.9 in STNxV and 0.8 in STNxR,
P , 0.01), as described previously [29, 32].
DISCUSSION
This study documents that OPN mRNA and protein
are markedly up-regulated following STNx. The up-reg-
ulation of glomerular and tubular OPN expression was
strongly associated with macrophage accumulation and
progressive renal injury and correlated with the develop-
ment of tubulitis, tubulointerstitial fibrosis, proteinuria,
and renal function impairment. The observation that
both treatment with an AT1 receptor antagonist or an
ACE inhibitor inhibited the OPN expression suggests
that Ang II either directly or indirectly regulates OPN
expression in this model. Furthermore, the close asso-
ciation between the inhibition of OPN expression and
Fig. 4. Quantitation of tubular OPN expression and macrophage accu-the reduction in macrophage infiltration and tubulointer-
mulation in the development of tubulitis in the rat remnant kidney.stitial injury suggest that one of the mechanisms by which
(A) Comparison of ED11 macrophages within or surrounding OPN1
Ang II blockade is effective may be via inhibition of (j) or OPN2 (h) tubules. (B) Tubulitis in OPN1 (j) or OPN2 (h)
tubules. Data are expressed as mean 6 SEM for five animals. **P ,OPN expression.
0.01; ***P , 0.001 by unpaired Student’s t-test.It is now well known that OPN is a potent chemotactic
and adhesive molecule for monocyte/macrophages [1–3].
An association between up-regulation of tubular OPN
expression and focal macrophage infiltration has been degree of macrophage accumulation and the develop-
described in a number of experimental models of renal ment of tubulitis and interstitial fibrosis [5, 14, 23]. In
injury, suggesting a pathological role for OPN in progres- contrast to our previous finding in a rat model of anti-
sive glomerular and tubulointerstitial injury [5, 12–23]. GBM glomerulonephritis in which glomerular OPN ex-
Interestingly, in models in which tubulointerstitial injury pression and macrophage accumulation are prominent
is mild or transient, OPN expression is also transient [12]. [5, 23], only a small, but significant number of glomerular
Fewer studies have been performed of chronic models of OPN1 cells and macrophages were found. This may be
renal injury, but some sustained OPN expression that due to the less severe glomerular injury seen in this dis-
correlates with chronic macrophage accumulation has ease model compared with anti-GBM crescentic glomer-
been shown [18]. The functional role of OPN in tubuloin- ulonephritis. Importantly, the documentation that OPN
terstitial injury has been further confirmed by a recent expression preceded the macrophage accumulation in
study of obstructive nephropathy induced in OPN null the current model provides strong suggestive evidence
mutant mice (OPN2/2). Indeed, the OPN2/2 mice ex- that OPN may be at least partially responsible for the
hibited a significant reduction in early interstitial macro- subsequent macrophage infiltration. Similar observa-
phage influx and fibrosis [22]. The current study is of tions were noted in a model of tubulointerstitial injury
some interest as the increase in OPN was progressive induced by Ang II infusion [13].
and eventually was observed in over 80% of cortical The mechanism by which OPN may promote macro-
tubules. Furthermore, as noted in other models, the tubu- phage accumulation within the kidney is likely through
its adhesive and chemotactic functions. OPN can bindlar OPN expression correlated with both the sites and
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Table 1. Correlation of osteopontin (OPN) expression with macrophage accumulation, histology and renal function
Glomerular Interstitial Glomerulo- Tubulointerstitial Serum
OPN expression ED11 cells ED11 cells sclerosis fibrosis Tubulitis Proteinuria Serum urea creatinine
Glomerulus 0.472c — 0.153 — — 0.499c 0.356b 0.535c
Tubules — 0.457b — 0.259a 0.780c 0.441c 0.303b 0.507c
Data are from 25 animals with STNx analyzed using the Pearson single correlation coefficient.
a P , 0.05, b P , 0.01, c P , 0.001
Fig. 5. Northern blot demonstrates the inhi-
bition of OPN mRNA expression in rat rem-
nant kidneys by valsartan or ramipril. North-
ern blot analysis shows that OPN mRNA is
markedly up-regulated at week 12 after STNx,
while treatment with valsartan (STNxV) and
ramipril (STNxR) abrogated OPN mRNA up-
regulation. OPN mRNA is normalized for
GAPDH mRNA (OPN/GAPDH ratio). Shown
are the mean 6 SEM for five animals. **P ,
0.01 compared with sham-operated animals.
Fig. 6. In situ hybridization and immuno-
staining demonstrate the inhibition of glomer-
ular and tubular OPN mRNA and protein
expression in the rat remnant kidney by val-
sartan and ramipril. Shown are OPN mRNA
(A and B) and OPN protein (C and D) expres-
sion in glomeruli and tubules in sham-oper-
ated (h), untreated disease control (STNx,
j), valsartan-treated (STNxV, ), and rami-
pril-treated (STNxR, ) animals. Data are
expressed as mean 6 SEM for eight animals.
***P , 0.001 compared with sham-operated
animals.
to a number of ligands including the avb3 integrin and glomerulonephritis causes marked inhibition of renal
OPN and its ligand CD44 expression, which suggestsCD44, an adhesion molecule that is expressed by infiltrat-
ing leukocytes and markedly up-regulated by intrinsic kid- that the OPN2CD44 interaction may promote leukocyte
adhesion in the development of both glomerular andney cells during the disease [2, 5, 23]. The administration
of a neutralizing anti-OPN antibody to rat anti-GBM tubulointerstitial injury [23]. However, not all isoforms
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fibrosis [13]. Kaneto et al have also reported that in a
unilateral model of obstruction, the administration of
an ACE inhibitor could prevent OPN protein but not
mRNA expression, and this was also associated with a
reduction in macrophage infiltration and injury [27]. AT1
receptor blocker therapy also reduces OPN expression
and macrophage accumulation in a model of cyclo-
sporine-induced nephropathy [14]. In contrast, Fischer
et al reported that ACE inhibitors increase OPN expres-
sion in the kidneys of rats with streptozotocin-induced
diabetes, an effect that was mediated by bradykinin gen-
erated by the ACE inhibitor [28]. However, the observa-
tion in the current study that both ACE inhibitor and
AT1 receptor antagonist therapy were protective strongly
implicates a role for Ang II in the up-regulation of OPN
in this model.
The mechanism by which Ang II stimulates OPN ex-
pression in tubules in this model could be direct or indi-
rect. Ang II may act directly to stimulate tubular expres-
sion of OPN [26]. However, Ang II might also induce
OPN expression indirectly, such as by inducing glomeru-
lar hypertension and proteinuria, the latter of which has
been shown to induce tubular OPN expression in a model
of protein overload nephropathy [16]. Ang II is also
able to induce transforming growth factor-b (TGF-b)
expression in vitro [37], which in turn, up-regulates OPN
expression in cultured normal rat tubular epithelial cells
[38]. In this disease model, we have shown that blocking
Ang II activity significantly inhibited the up-regulationFig. 7. Effect of Ang II blockade on tubular OPN expression and
macrophage accumulation in the development of tubulitis in rat remnant of renal TGF-b [24]. This suggests that Ang II-induced
kidney. (A) Shown is the suppressive effect of Ang II blockade on TGF-b production may play a role in the up-regulationED11 macrophage accumulation within and/or surrounding the OPN1
of renal OPN expression in the present study.or OPN2 tubules. (B) Shown is the suppressive effect of Ang II blockade
in the development of tubulitis. Symbols are: (h) sham-operated rats; An amplification system for OPN expression is also
(j) untreated controls; ( ) valsartan-treated rats; ( ) ramipril-treated possible. We have recently shown that IL-1 can act di-animals. Data are expressed as mean 6 SEM for eight animals per
rectly to up-regulate OPN expression in renal epithelialgroup. ***P , 0.001 compared with sham animals by ANOVA.
cells in vivo and in vitro [39]. Activated macrophages
are a major source of IL-1; therefore, local macrophage
accumulation could further induce tubular OPN expres-of CD44 react with OPN and differentially regulate mac-
sion with the additional recruitment of more monocyte-rophage interleukin-12 (IL-12) and IL-10 cytokine ex-
macrophages. The observation of continuously increasedpression [33]. It is also important to recognize that other
up-regulation of tubular OPN expression through outchemotactic and adhesive factors are also likely involved
the entire disease course may possibly be accounted forin the macrophage accumulation in these models. In-
by this inflammatory amplification response.deed, functional studies have documented roles for the
In summary, this study demonstrates that Ang II ischemokines such as monocyte chemoattractant protein-
a key stimulator to up-regulate renal OPN expression1, intercellular adhesion molecule-1, and macrophage
following STNx. Inhibition of OPN expression may bemigration inhibitory in different models [34–36].
one of the mechanisms by which Ang II blockade sup-An important finding in the study was the demonstra-
tion that either an AT1 receptor blocker or an ACE presses macrophage-mediated renal injury in the rem-
inhibitor blocked the up-regulation of OPN and the sub- nant kidney.
sequent macrophage infiltration and tubulointerstitial in-
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